Login

Leqembi 100 mg/mL concentrate for solution for infusion

*
Pharmacy Only: Prescription

  • Company:

    Eisai Ltd

  • Status:

    Updated

  • Legal Category:

    Product subject to restricted prescription (C)

  • Active Ingredient(s):

    Lecanemab

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

qrcode image

Scan the QR code or enter an email to access and share this medicine:

Updated on 10 October 2025

File name

ROI Leqembi PIL Sept 2025.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 6 - what the product contains

Updated on 10 October 2025

File name

ROI Leqembi SmPC Sept 2025.pdf

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 7 - Marketing authorisation holder

Legal category:Product subject to restricted prescription (C)

Updated on 08 September 2025

File name

ROI Leqembi SmPC June 2025.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to restricted prescription (C)

Updated on 08 September 2025

File name

ROI Leqembi PIL April 2025.pdf

Reasons for updating

  • New PIL for new product

Eisai Ltd

Eisai Ltd